AstraGin, a nutraceutical supplement containing Astragalus Root and San-qi Ginseng extracts, has shown positive effects on digestive health in patients with ulcerative colitis, according to a study published in the Journal of Biochemistry and Biotechnology. The supplement improved intestinal barrier integrity and reduced MPO, a biomarker of ulcerative colitis, by 58%. AstraGin also induced positive changes in gut microbes, increased immune cells, and improved L-arginine absorption, while positively impacting ghrelin, a hormone that stimulates appetite.
Although the study was conducted on a small group of patients, the positive results indicate the need for further research to explore the potential of AstraGin in treating inflammatory bowel diseases. The researchers behind AstraGin are investigating multiple pathways on how the supplement supports bioavailability and promotes a better intestinal environment. With further research and development, AstraGin could become a valuable nutraceutical product in the market, especially for those with digestive conditions.
Overall, the positive effects of AstraGin on digestive health offer a promising solution for those with ulcerative colitis and other inflammatory bowel diseases. Nutraceutical players can leverage modern technologies to develop and commercialize products that support digestive health, addressing the growing demand for preventive healthcare solutions.
